
Advanced Visualization Market

Advanced Visualization Market Size, Share, Growth & Industry Analysis, By Imaging Modality (MRI, CT, Ultrasound, Radiotherapy, Nuclear Medicine, and Others), By Clinical Application (Oncology, Cardiology, Neurology, Radiology, Orthopedics, and Others), and Regional Analysis, 2024-2031
Pages : 120
Base Year : 2023
Release : July 2024
Report ID: KR882
TABLE OF CONTENT
1 INTRODUCTION OF THE GLOBAL ADVANCED VISUALIZATION MARKET
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 Data Collection
3.1.1 Secondary Sources
3.1.2 Primary Sources
3.1.3 Research Flow
3.2 Subject Matter Expert Advice
3.3 Quality Check
3.4 Final Review
3.5 Bottom-Up Approach
3.6 Top-down Approach
4 GLOBAL ADVANCED VISUALIZATION MARKET OUTLOOK
4.1 Market Evolution
4.2 Overview
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.3.4 Challenges
4.4 Pricing Analysis
4.5 Porter’s Five Forces Analysis
4.6 Value Chain Analysis
4.7 Macroeconomic Analysis
5 IMPACT OF RUSSIA-UKRAINE WAR
6 GLOBAL ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY
6.1 Overview
6.2 Magnetic Resonance Imaging (MRI)
6.3 Computed Tomography (CT)
6.4 Ultrasound
6.5 Radiotherapy (RT)
6.6 Nuclear Medicine
6.7 Others
7 GLOBAL ADVANCED VISUALIZATION MARKET, BY CLINICAL APPLICATION
7.1 Overview
7.2 Oncology
7.3 Cardiology
7.4 Neurology
7.5 Radiology
7.6 Orthopedics
7.7 Others
8 GLOBAL ADVANCED VISUALIZATION MARKET, BY GEOGRAPHY
8.1 Overview
9 NORTH AMERICA
9.1 U.S.
9.2 Canada
9.3 Mexico
10 EUROPE
10.1 Germany
10.2 U.K.
10.3 France
10.4 Italy
10.5 Spain
10.6 Russia
10.7 Rest of Europe
11 ASIA-PACIFIC
11.1 China
11.2 Japan
11.3 India
11.4 South Korea
11.5 Rest of Asia-Pacific
12 MIDDLE EAST & AFRICA
12.1 GCC
12.2 South Africa
12.3 North Africa
12.4 Rest of Middle East & Africa
13 LATIN AMERICA
13.1 Brazil
13.2 Argentina
13.3 Rest of South America
14 GLOBAL ADVANCED VISUALIZATION MARKET COMPETITIVE LANDSCAPE
14.1 Overview
14.2 Key Developments
14.3 Key Strategic Developments
14.4 Company Market Ranking
14.5 Regional Footprint
14.6 Industry Footprint
15 COMPANY PROFILES
15.1 Agfa-Gevaert Group
15.1.1 Key Facts
15.1.2 Financial Overview
15.1.3 Product Benchmarking
15.1.4 Recent Developments
15.1.5 Winning Imperatives
15.1.6 Current Focus & Strategies
15.1.7 Threat from competition
15.1.8 SWOT Analysis
15.2 Canon Inc. (Canon Medical Systems Corporation)
15.2.1 Key Facts
15.2.2 Financial Overview
15.2.3 Product Benchmarking
15.2.4 Recent Developments
15.2.5 Winning Imperatives
15.2.6 Current Focus & Strategies
15.2.7 Threat from competition
15.2.8 SWOT Analysis
15.3 Carestream Health
15.3.1 Key Facts
15.3.2 Financial Overview
15.3.3 Product Benchmarking
15.3.4 Recent Developments
15.3.5 Winning Imperatives
15.3.6 Current Focus & Strategies
15.3.7 Threat from competition
15.3.8 SWOT Analysis
15.4 Fujifilm Holdings Corporation
15.4.1 Key Facts
15.4.2 Financial Overview
15.4.3 Product Benchmarking
15.4.4 Recent Developments
15.4.5 Winning Imperatives
15.4.6 Current Focus & Strategies
15.4.7 Threat from competition
15.4.8 SWOT Analysis
15.5 General Electric Company (GE Healthcare)
15.5.1 Key Facts
15.5.2 Financial Overview
15.5.3 Product Benchmarking
15.5.4 Recent Developments
15.5.5 Winning Imperatives
15.5.6 Current Focus & Strategies
15.5.7 Threat from competition
15.5.8 SWOT Analysis
15.6 Koninklijke Philips NV
15.6.1 Key Facts
15.6.2 Financial Overview
15.6.3 Product Benchmarking
15.6.4 Recent Developments
15.6.5 Winning Imperatives
15.6.6 Current Focus & Strategies
15.6.7 Threat from competition
15.6.8 SWOT Analysis
15.7 Pro Medicus Ltd
15.7.1 Key Facts
15.7.2 Financial Overview
15.7.3 Product Benchmarking
15.7.4 Recent Developments
15.7.5 Winning Imperatives
15.7.6 Current Focus & Strategies
15.7.7 Threat from competition
15.7.8 SWOT Analysis
15.8 Siemens Healthcare S.A
15.8.1 Key Facts
15.8.2 Financial Overview
15.8.3 Product Benchmarking
15.8.4 Recent Developments
15.8.5 Winning Imperatives
15.8.6 Current Focus & Strategies
15.8.7 Threat from competition
15.8.8 SWOT Analysis
15.9 Terarecon Inc.
15.9.1 Key Facts
15.9.2 Financial Overview
15.9.3 Product Benchmarking
15.9.4 Recent Developments
15.9.5 Winning Imperatives
15.9.6 Current Focus & Strategies
15.9.7 Threat from competition
15.9.8 SWOT Analysis
15.10 Toshiba Corp.
15.10.1 Key Facts
15.10.2 Financial Overview
15.10.3 Product Benchmarking
15.10.4 Recent Developments
15.10.5 Winning Imperatives
15.10.6 Current Focus & Strategies
15.10.7 Threat from competition
15.10.8 SWOT Analysis
LIST OF TABLES
TABLE 1 Global Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 2 Global Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 3 Global Advanced Visualization Market Revenue, By Geography, 2021 – 2031 (USD Million)
TABLE 4 North America Advanced Visualization Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 5 North America Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 6 North America Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 7 US Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 8 US Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 9 Canada Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 10 Canada Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 11 Mexico Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 12 Mexico Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 13 Europe Advanced Visualization Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 14 Europe Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 15 Europe Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 16 Germany Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 17 Germany Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 18 France Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 19 France Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 20 U.K. Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 21 U.K. Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 22 Spain Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 23 Spain Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 24 Italy Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 25 Italy Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 26 Russia Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 27 Russia Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 28 Rest of Europe Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 29 Rest of Europe Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 30 Asia-Pacific Advanced Visualization Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 31 Asia-Pacific Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 32 Asia-Pacific Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 33 China Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 34 China Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 35 Japan Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 36 Japan Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 37 India Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 38 India Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 39 South Korea Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 40 South Korea Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 41 Rest of Asia-Pacific Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 42 Rest of Asia-Pacific Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 43 Middle East and Africa Advanced Visualization Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 44 Middle East and Africa Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 45 Middle East and Africa Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 46 GCC Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 47 GCC Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 48 North Africa Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 49 North Africa Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 50 South Africa Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 51 South Africa Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 52 Rest of Middle East & Africa Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 53 Rest of Middle East & Africa Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 54 Latin America Advanced Visualization Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 55 Latin America Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 56 Latin America Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 57 Brazil Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 58 Brazil Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 59 Argentina Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 60 Argentina Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 61 Rest of Latin America Advanced Visualization Market Revenue, By Imaging Modality, 2021 – 2031 (USD Million)
TABLE 62 Rest of Latin America Advanced Visualization Market Revenue, By Clinical Application, 2021 – 2031 (USD Million)
TABLE 63 Company Market Ranking
TABLE 64 Regional Footprint
TABLE 65 Product Benchmarking
TABLE 66 Recent Developments
TABLE 67 Winning Imperatives
LIST OF FIGURES
FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global Advanced Visualization Market 2021-2031 (USD Million)
FIG. 4 Global Advanced Visualization Market Geographical Analysis (CAGR %)
FIG. 5 Global Advanced Visualization Absolute Market Opportunity (USD Million)
FIG. 6 Global Advanced Visualization Market Attractiveness (USD Million)
FIG. 7 Global Advanced Visualization Market, By Imaging Modality, 2021-2031 (USD Million)
FIG. 8 Global Advanced Visualization Market, By Clinical Application, 2021-2031 (USD Million)
FIG. 9 Research Methodology
FIG. 10 Research Process
FIG. 11 Bottom-Up Approach
FIG. 12 Top-Bottom Approach
FIG. 13 Market Dynamics Overview
FIG. 14 Porter's Five Forces Analysis
FIG. 15 Value Chain Analysis
FIG. 16 Macroeconomic Analysis
FIG. 17 Global Advanced Visualization Market Revenue Share, By Imaging Modality, 2023 and 2031 (%)
FIG. 18 Global Advanced Visualization Market Revenue Share, By Clinical Application, 2023 and 2031 (%)
FIG. 19 Global Advanced Visualization Market Revenue Share, By Geographic Regions, 2023 and 2031 (%)
FIG. 20 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 21 North America Advanced Visualization Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 22 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 23 Europe Advanced Visualization Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 24 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 25 Asia-Pacific Advanced Visualization Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 26 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 27 Middle East & Africa Advanced Visualization Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 28 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 29 Latin America Advanced Visualization Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 30 Key Strategic Development
FIG. 31 Key Facts
FIG. 32 Financial Overview
FIG. 33 SWOT Analysis